The DKD had higher rates of anti-hypertensive, angiotensin-converting enzyme inhibitors (ACEI), and angiotensin ii inhibitors (ARB), anti-diabetic drugs, lipid-lowering agents, and aspirin compared to other groups (Table 1). The gene discussed is ACE; the disease is diabetic kidney disease.